First and second generations of COX-2 selective inhibitors

被引：1
|
作者：
de Leval, X
Julémont, F
Benoit, V
Frederich, M
Pirotte, B
Dogné, JM
机构：
[1] Univ Liege, Nat & Synth Drugs Res Ctr, Dept Med Chem, Med Chem Lab, B-4000 Liege, Belgium
[2] Univ Liege, Cellular & Moll Therapeut Ctr, B-4000 Liege, Belgium
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2004年 / 4卷 / 06期
关键词：
COX-2; inhibitors; selectivity; pre-clinical data;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The identification and characterization of the inducible form of cyclooxygenases (COX-2) stimulated the investigations to develop efficient, non-steroidal anti-inflammatory drugs (NSAIDs) with reduced side effects (essentially gastro-intestinal toxicity) compared to classical NSAIDs. This review focuses on the chemical and pharmacological properties (pre-clinical data) of marketed COX-2 inhibitors.
引用
收藏
页码：597 / 601
页数：5
相关论文
共 50 条
  • [41] Selective COX-2 inhibitors: is the water becoming muddy?
    Wallace, JL
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (01) : 4 - 6
  • [42] COX-2 selective inhibitors - important lessons learned
    Maxwell, SRJ
    Webb, DJ
    LANCET, 2005, 365 (9458): : 449 - 451
  • [43] Clinical pharmacology of novel selective COX-2 inhibitors
    Tacconelli, S
    Capone, ML
    Patrignani, P
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (06) : 589 - 601
  • [44] Aspirin, selective COX-2 inhibitors and gastrotolerance - Foreword
    Fiorucci, S
    Morelli, A
    Porro, GB
    DIGESTIVE AND LIVER DISEASE, 2001, 33 : S1 - S1
  • [45] Selective COX-2 inhibitors vs NSAIDs discussed
    Reactions Weekly, 2002, 906 (1) : 3 - 3
  • [46] Risk of hyperkalemia associated with selective COX-2 inhibitors
    Aljadhey, Hisham
    Tu, Wanzhu
    Hansen, Richard A.
    Blalock, Susan
    Brater, Craig
    Murray, Michael D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (11) : 1194 - 1198
  • [47] The future of NSAID therapy: selective COX-2 inhibitors
    Vane, JR
    Botting, RM
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, 54 (01) : 7 - 9
  • [48] No increase in acute MI with selective COX-2 inhibitors
    Reactions Weekly, 2003, 947-948 (1) : 5 - 5
  • [49] Design of peptides and peptidomimetics as COX-2 selective inhibitors
    Kothekar, V
    Sahi, S
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2002, 577 (2-3): : 107 - 120
  • [50] NSAID COX-2 selective inhibitors: hopes and incertitudes
    Bannwarth, B
    PRESSE MEDICALE, 1999, 28 (22): : 1180 - 1181
12345